Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, February 23, 2012
Technology Networks
 
Register |
Home Page>Blog
  Genomics Blog
Scientific News
Genomic Sequencing in Clinical Trials
In this article, researchers from Northwestern University Feinberg review the current and future directions of clinical research with respect to genomic sequencing.
Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer
Findings highlight clinical application of next-generation sequencing to suggest targeted therapeutic options for patients.
Transformational Fruit Fly Genome Catalog Completed
Scientists now have a reference manual that should speed gene discoveries in everything from pest control to personalized medicine.
Animal Cell Therapies Announces Cell Inventory Value at $6 Million
The evaluation demonstrates the importance of this first step in the company's mission to improve and extend the lives of dogs through innovative stem cell products and services.
Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain Cancer
Company announced clinical trial testing of its lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.
Drug Halts Organ Damage in Inflammatory Genetic Disorder
NIH study shows benefits of long-term Kineret therapy in people with NOMID.
Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies
Data highlights novel immunomodulatory effects of entinostat in renal and prostate cancer models.
Hunting Could Hurt Genetic Diversity of Sandhill Cranes, UW Research Suggests
Research uses DNA fingerprinting to assess the genetic makeup of cranes.
Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based Therapeutics
AVI BioPharma, Inc. have announced positive safety results from all six dose cohorts in the single ascending dose studies of AVI-6002 and AVI-6003, AVI's lead drug candidates being evaluated for the treatment of Ebola virus and Marburg virus, respectively.
Compugen Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy
Findings support CGEN-15001T's potential as a powerful drug target for cancer immunotherapy.

Biobanking - Collaborating for Global R&D and Investment
19 May 2011

With unquestionable commercial growth opportunities, biobanks need to deliver quality samples to create value for biomarker discovery and personalised medicine. However who should implement quality control; should biobanks be self regulating or should an independent certified organisation develop a system of accreditation?

SMi's inaugural Biobanking conference is the perfect opportunity to network with the industry's leading figures and contribute to the successful future of drug discovery. Join us at the Crowne Plaza - The City, London, on the 11th - 12th July to discuss the latest developments in the biobanking arena. Take part in this brilliant forum which aims to bridge the gap between the worlds' leading academia and the pharma industry.

One of the focal points at this conference will be the impact of drug discovery on neurology disorders. Dr Rivka Ravid, Senior Scientist, Royal Dutch Academy of Sciences, Brain Bank Consultants, will use her wealth of knowledge to inform delegates of the pitfalls and practicalities in the daily practice of Brain Banks for biomedical research.

Dr Sven Kili, Global Medical Director - Cell Therapy & Regenerative Medicine, Genzyme, provides a thorough insight regarding the application of regenerative medicine. Like most strands of medical research, the value and ultimate success of regenerative medicine in tissue engineering relies heavily on the ability to maintain quality standards in a sample collection.

The forum will also look at the operational considerations within biobanking and the need for standardisation within the various networks. George Tokiwa, Associate Scientific Director at Merck will spearhead a panel-led debate regarding the most suitable system of accreditation with use of case studies to highlight best practice between biobanks.

These are just a few of the reasons why you should attend SMi's Biobanking conference. For further information please visit the website:

http://www.smi-online.co.uk/bio-banking-event63.asp

**Keep an eye on this blog, updates to follow!**

 

Posted By: awilliamson@smi-online.co.uk4 Comments
 

Welcome To Our Blog
17 May 2011

Firstly hello and welcome to the new Technology Networks Blog.

The blog section on all Technology Networks communities allows you to share your latest research, product developments and experiences with researchers and scientific professionals in your chosen field.

So why not share your views and experiences with our global subscribers?

Happy Blogging!!

Posted By: A.Board0 Comments
 
<< 1 >>
Showing Results 1 - 2 of 2
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net